See All Slides - tctmd.com

Slides

$Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study$

Presentation Cell Therapy 2013

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Presenter: Thomas J. Povsic

January 22, 2013

Presentation Cell Therapy 2013

MPC's for Ischemic and Nonischemic Heart Failure

Presenter: Emerson C. Perin

January 22, 2013

Presentation Cell Therapy 2013

BMAC for CLI: Status of a Phase 3 Trial

Presenter: Amit Patel

January 22, 2013

Presentation Cell Therapy 2013

SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study

Presenter: Marc S. Penn

January 22, 2013

Presentation Cell Therapy 2013

A Randomized Double Blinded Study to Evaluate The Effect of Bone Marrow- Derived Mononuclear Stem Cells on Tissue Perfusion in Patients with Intermittent Claudication

Presenter: Emerson C.Perin

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Presenter: Kenneth Borow

January 22, 2013

Presentation Cell Therapy 2013

REVIVE: Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy

Presenter: Amit N. Patel

January 22, 2013

Presentation Cell Therapy 2013

Cardiac-derived Stem Cells Post-MI: CADUCEUS and ALLSTAR

Presenter: Eduardo Marb?n

January 22, 2013

Presentation Cell Therapy 2013

EXCELLENT Trial Design

Presenter: J?r?me Roncalli

January 22, 2013

Presentation Cell Therapy 2013

Multimodality Imaging: Enhancing Outcomes with Available Technology

Presenter: Amish Raval

January 22, 2013

Advertisement

Slides

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

MPC's for Ischemic and Nonischemic Heart Failure

BMAC for CLI: Status of a Phase 3 Trial

SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study

A Randomized Double Blinded Study to Evaluate The Effect of Bone Marrow- Derived Mononuclear Stem Cells on Tissue Perfusion in Patients with Intermittent Claudication

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

REVIVE: Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy

Cardiac-derived Stem Cells Post-MI: CADUCEUS and ALLSTAR

EXCELLENT Trial Design

Multimodality Imaging: Enhancing Outcomes with Available Technology

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content